Tags

Type your tag names separated by a space and hit enter

EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Cell Growth Differ. 1996 Apr; 7(4):429-37.CG

Abstract

Among primitive neuroectodermal tumors, Ewing tumors are characterized by a gene rearrangement recombining the 5'-EWS gene portion with one of two ETS-related proto-oncogenes, FLI-1 or ERG, in roughly 90 and 10% of cases, respectively. We attempted to antagonize EWS/FLI-1 function in Ewing tumor cell lines. As a control, a cell line derived from another small round cell tumor of neuroectodermal origin, neuroblastoma, was used. This cell line was found to express almost identical patterns of ETS proteins except for EWS/FLI-1 and a novel, ELF-related gene product. Stable expression of antisense EWS/FLI-1 cDNA resulted in decreased endogenous EWS/FLI-1 RNA levels and growth reduction of ET cells but not of neuroblastoma cells. DNA-binding FLI-1 derivatives localizing to the nucleus in which the 5'-EWS regulatory domain was replaced by bacterial beta-galactosidase dominantly modulated transcriptional transactivation from a degenerate ETS-binding motif. Transient transfection of these dominant-negative recombinants resulted in a significant decrease in the relative number of mitoses in four Ewing tumor cell lines tested but not in the neuroblastoma cell line. The presented evidence for modulation of tumor cell proliferation by EWS/FLI-1 antagonists suggests a causal role for EWS/FLI-1-mediated gene activation in the malignant transformation of the enigmatic Ewing tumor-precursor cell.

Authors+Show Affiliations

Childrens Cancer Research Institute, St. Anna Kinderspital, Vienna, Austria.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

9052984

Citation

Kovar, H, et al. "EWS/FLI-1 Antagonists Induce Growth Inhibition of Ewing Tumor Cells in Vitro." Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research, vol. 7, no. 4, 1996, pp. 429-37.
Kovar H, Aryee DN, Jug G, et al. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Cell Growth Differ. 1996;7(4):429-37.
Kovar, H., Aryee, D. N., Jug, G., Henöckl, C., Schemper, M., Delattre, O., Thomas, G., & Gadner, H. (1996). EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research, 7(4), 429-37.
Kovar H, et al. EWS/FLI-1 Antagonists Induce Growth Inhibition of Ewing Tumor Cells in Vitro. Cell Growth Differ. 1996;7(4):429-37. PubMed PMID: 9052984.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. AU - Kovar,H, AU - Aryee,D N, AU - Jug,G, AU - Henöckl,C, AU - Schemper,M, AU - Delattre,O, AU - Thomas,G, AU - Gadner,H, PY - 1996/4/1/pubmed PY - 1996/4/1/medline PY - 1996/4/1/entrez SP - 429 EP - 37 JF - Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research JO - Cell Growth Differ VL - 7 IS - 4 N2 - Among primitive neuroectodermal tumors, Ewing tumors are characterized by a gene rearrangement recombining the 5'-EWS gene portion with one of two ETS-related proto-oncogenes, FLI-1 or ERG, in roughly 90 and 10% of cases, respectively. We attempted to antagonize EWS/FLI-1 function in Ewing tumor cell lines. As a control, a cell line derived from another small round cell tumor of neuroectodermal origin, neuroblastoma, was used. This cell line was found to express almost identical patterns of ETS proteins except for EWS/FLI-1 and a novel, ELF-related gene product. Stable expression of antisense EWS/FLI-1 cDNA resulted in decreased endogenous EWS/FLI-1 RNA levels and growth reduction of ET cells but not of neuroblastoma cells. DNA-binding FLI-1 derivatives localizing to the nucleus in which the 5'-EWS regulatory domain was replaced by bacterial beta-galactosidase dominantly modulated transcriptional transactivation from a degenerate ETS-binding motif. Transient transfection of these dominant-negative recombinants resulted in a significant decrease in the relative number of mitoses in four Ewing tumor cell lines tested but not in the neuroblastoma cell line. The presented evidence for modulation of tumor cell proliferation by EWS/FLI-1 antagonists suggests a causal role for EWS/FLI-1-mediated gene activation in the malignant transformation of the enigmatic Ewing tumor-precursor cell. SN - 1044-9523 UR - https://www.unboundmedicine.com/medline/citation/9052984/EWS/FLI_1_antagonists_induce_growth_inhibition_of_Ewing_tumor_cells_in_vitro_ L2 - http://cgd.aacrjournals.org/cgi/pmidlookup?view=long&pmid=9052984 DB - PRIME DP - Unbound Medicine ER -